跳至主要内容
临床试验/IRCT20201028049175N2
IRCT20201028049175N2尚未招募2 期

Comparison of the efficacy of Atorvastatin and Rosuvastatin in atrial fibrillation incidence after coronary artery bypass graft surgery (CABG)

Arak University of Medical Sciences0 个研究点目标入组 104 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
104

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • All of patients reffered to Amiralmomenin hospital for elective CABG surgery
  • Patients with 40 or more than 40 EF
  • Patients with On-pump method in surgery

排除标准

  • Using of antiarhythmic drugs especially Amiodarone
  • History of AF
  • Valvular dysfunction
  • Other surgeries with CABG
  • Organic disease (i.e chronic renal failure stage 3 and 4), thyroid dysfunction, immunosuppression, cancer, central nervous system disease, brain vessels disease and history of CerebroVascular Accident, hormonal diseases, rise of liver enzymes)
  • Hypo/hyperkalemia
  • Dialysis (abnormal Cr)
  • Use of anti-inflammatory drugs
  • Psychological disorders

研究者

相似试验

Comparison of the efficacy of Atorvastatin and... | 临床试验